BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/14/2019 11:18:56 AM | Browse: 1527 | Download: 2711
Publication Name World Journal of Gastroenterology
Manuscript ID 51677
Country South Korea
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Cohort Study
Article Title Tailored eradication vs empirical bismuth-containing quadruple therapy as first-line Helicobacter eradication: A comparative, open trial
Manuscript Source Invited Manuscript
All Author List Youn I Choi, Jun Won Chung, Dong Kyun Park, Kyoung Oh Kim, Kwang An Kwon, Yoon Jae Kim and Ja Young Seo
ORCID
Author(s) ORCID Number
Youn I Choi http://orcid.org/0000-0001-6561-6752
Jun Won Chung http://orcid.org/0000-0002-0869-7661
Dong Kyun Park http://orcid.org/0000-0002-2862-6641
Kyoung Oh Kim http://orcid.org/0000-0002-5365-2550
Kwang An Kwon http://orcid.org/0000-0002-2947-2111
Yoon Jae Kim http://orcid.org/0000-0001-8477-6823
Ja Young Seo http://orcid.org/0000-0002-1894-1365
Funding Agency and Grant Number
Corresponding Author Jun Won Chung, MD, PhD, Associate Professor, Doctor, Doctor, Division of Gastroenterology, Department of Internal Medicine, Gachon University, Gil Medical Center, 21, Namdong-daero 774beon-gil, Namdong-gu, Incheon 21565, South Korea. junwonchung@hanmail.net
Key Words Helicobacter pylori; Eradication; Tailored; Empirical; Quadruple;
Core Tip Few studies have compared the efficacy and safety profile of a tailored eradication (TR) strategy based on the presence of a 23S ribosomal RNA point mutation with those of empirical bismuth-based quadruple therapy (EBQT) as first-line eradication for Helicobacter pylori infection in Korean patients. In this prospective, open-label, comparative study results, the first-line eradication rate of H. pylori did not statistically differ between the strategy of TR and EBQT. However, the rate of eradication-related side effects was significantly lower in TR than EBQT strategy. TR H. pylori eradication using DPO-PCR may be equally efficacious, with less treatment-related complications, compared to EBQT in Korea, where clarithromycin resistance is high.
Publish Date 2019-12-14 11:18
Citation Choi YI, Chung JW, Park DK, Kim KO, Kwon KA, Kim YJ, Seo JY. Tailored eradication vs empirical bismuth-containing quadruple therapy as first-line Helicobacter eradication: A comparative, open trial. World J Gastroenterol 2019; 25(46): 6743-6751
URL https://www.wjgnet.com/1007-9327/full/v25/i46/6743.htm
DOI https://dx.doi.org/10.3748/wjg.v25.i46.6743
Full Article (PDF) WJG-25-6743.pdf
Full Article (Word) WJG-25-6743.docx